Mark De Ridder, MD, PhD
Head of the Radiotherapy Department
UZ Brussel, Vrije Universiteit Brussel
Prof. Mark De Ridder graduated at the medical school of the Vrije Universiteit Brussel (VUB) in 1998 with summa cum lauda. He combined his training in Radiotherapy and Oncology with a doctoral fellowship (FWO-Vlaanderen) and defended his PhD “Hypoxic tumor cell radiosensitization through nitric oxide synthase: role of the NF-kB signaling pathway” in 2005. He was nominated professor in medicine at the VUB in 2008 and Head of the Radiotherapy Department of the UZ Brussel in 2010. Mark is vice-chairman of the board of directors and vice-president of the medical council of the UZ Brussel. Prof. De Ridder’s translational research program is focused on stereotactic radiotherapy, colorectal cancer and combined immuno-radiotherapy. He is the promoter of 11 successfully defended PhD theses and the author of more than 165 peer-reviewed articles.
“We are pleased to be one of the first two centers in Belgium to receive Novalis Certification. This accreditation program stands for high standards in patient safety and reinforces our processes and procedures for these highly complex treatments. This confirms our leading position for linac-based radiosurgery of brain lesions in Belgium.”
Institution: UZ Brussel, Vrije Universiteit Brussel
Speciality: Radiotherapy
Title: Head of the Radiotherapy Department
Region: Belgium
Street: Laarbeeklaan 101
City: Brussels
Zip: 1090